XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 84 $ 552,531 $ (234) $ (528,345) $ 24,036
Balance (in shares) at Dec. 31, 2018 83,911,855   41,309    
Issuance of restricted stock (in shares) 23,000        
Warrants issued with debt financing   993     993
Forfeiture of restricted stock (in shares) (67,628)        
Issuance of common stock in At-the-Market offerings (net of offering costs) $ 5 27,494     27,499
Issuance of common stock in At-the-Market offerings (net of offering costs) (in shares) 4,715,000        
Compensation in respect of restricted stock granted to employees, directors and consultants   1,882     1,882
Net loss       (35,156) (35,156)
Balance at Mar. 31, 2019 $ 89 582,900 $ (234) (563,501) 19,254
Balance (in shares) at Mar. 31, 2019 88,582,227   41,309    
Balance at Dec. 31, 2018 $ 84 552,531 $ (234) (528,345) 24,036
Balance (in shares) at Dec. 31, 2018 83,911,855   41,309    
Net loss         (133,299)
Balance at Sep. 30, 2019 $ 97 635,989 $ (234) (661,643) (25,791)
Balance (in shares) at Sep. 30, 2019 96,670,197   41,309    
Balance at Mar. 31, 2019 $ 89 582,900 $ (234) (563,501) 19,254
Balance (in shares) at Mar. 31, 2019 88,582,227   41,309    
Issuance of restricted stock $ 1 (1)      
Issuance of restricted stock (in shares) 1,245,080        
Forfeiture of restricted stock (in shares) (38,418)        
Issuance of common stock (net of offering costs)   11     11
Issuance of common stock in At-the-Market offerings (net of offering costs) $ 3 28,392     28,395
Issuance of common stock in At-the-Market offerings (net of offering costs) (in shares) 3,616,359        
Compensation in respect of restricted stock granted to employees, directors and consultants   1,757     1,757
Net loss       (36,212) (36,212)
Balance at Jun. 30, 2019 $ 93 613,059 $ (234) (599,713) 13,205
Balance (in shares) at Jun. 30, 2019 93,405,248   41,309    
Issuance of restricted stock (in shares) 318,440        
Forfeiture of restricted stock (in shares) (5,334)        
Issuance of common stock in At-the-Market offerings (net of offering costs) $ 4 20,755     20,759
Issuance of common stock in At-the-Market offerings (net of offering costs) (in shares) 2,943,460        
Compensation in respect of restricted stock granted to employees, directors and consultants   2,075     2,075
Shares issued in connection with in-licensing agreements   100     100
Shares issued in connection with in-licensing agreements (in shares) 8,383        
Net loss       (61,930) (61,930)
Balance at Sep. 30, 2019 $ 97 635,989 $ (234) (661,643) (25,791)
Balance (in shares) at Sep. 30, 2019 96,670,197   41,309    
Balance at Dec. 31, 2019 $ 109 739,956 $ (234) (701,216) 38,615
Balance (in shares) at Dec. 31, 2019 109,425,243   41,309    
Issuance of restricted stock $ 1 (1)      
Issuance of restricted stock (in shares) 774,300        
Forfeiture of restricted stock (in shares) (10,000)        
Issuance of common stock in connection with exercise of options   80     80
Issuance of common stock in connection with exercise of options 19,750        
Compensation in respect of restricted stock granted to employees, directors and consultants   11,068     11,068
Net loss       (51,116) (51,116)
Balance at Mar. 31, 2020 $ 110 751,103 $ (234) (752,332) (1,353)
Balance (in shares) at Mar. 31, 2020 110,209,293   41,309    
Balance at Dec. 31, 2019 $ 109 739,956 $ (234) (701,216) 38,615
Balance (in shares) at Dec. 31, 2019 109,425,243   41,309    
Net loss         (191,163)
Balance at Sep. 30, 2020 $ 129 1,063,142 $ (234) (892,379) 170,658
Balance (in shares) at Sep. 30, 2020 128,959,861   41,309    
Balance at Mar. 31, 2020 $ 110 751,103 $ (234) (752,332) (1,353)
Balance (in shares) at Mar. 31, 2020 110,209,293   41,309    
Issuance of restricted stock $ 2 (2)      
Issuance of restricted stock (in shares) 2,208,529        
Forfeiture of restricted stock (in shares) (41,666)        
Issuance of common stock (net of offering costs) $ 10 165,032     165,042
Issuance of common stock (net of offering costs) (in shares) 9,775,000        
Issuance of common stock in connection with exercise of options   16     16
Issuance of common stock in connection with exercise of options 3,750        
Issuance of common stock in At-the-Market offerings (net of offering costs) $ 5 76,031     76,036
Issuance of common stock in At-the-Market offerings (net of offering costs) (in shares) 4,535,608        
Compensation in respect of restricted stock granted to employees, directors and consultants   7,370     7,370
Net loss       (52,884) (52,884)
Balance at Jun. 30, 2020 $ 127 999,550 $ (234) (805,216) 194,227
Balance (in shares) at Jun. 30, 2020 126,690,514   41,309    
Issuance of restricted stock $ 1 (1)      
Issuance of restricted stock (in shares) 915,000        
Forfeiture of restricted stock (in shares) (65,000)        
Issuance of common stock (net of offering costs)   (1)     (1)
Issuance of common stock in connection with exercise of options   38     38
Issuance of common stock in connection with exercise of options 9,347        
Issuance of common stock in At-the-Market offerings (net of offering costs) $ 1 35,226     35,227
Issuance of common stock in At-the-Market offerings (net of offering costs) (in shares) 1,410,000        
Compensation in respect of restricted stock granted to employees, directors and consultants   28,330     28,330
Net loss       (87,163) (87,163)
Balance at Sep. 30, 2020 $ 129 $ 1,063,142 $ (234) $ (892,379) $ 170,658
Balance (in shares) at Sep. 30, 2020 128,959,861   41,309